150 related articles for article (PubMed ID: 1509278)
1. The experimental and clinical rationale for the use of S-phase-specific radiosensitizers to overcome tumor cell repopulation.
McGinn CJ; Kinsella TJ
Semin Oncol; 1992 Aug; 19(4 Suppl 11):21-8. PubMed ID: 1509278
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitization and cell kinetics: clinical implications for S-phase-specific radiosensitizers.
Kinsella TJ
Semin Oncol; 1992 Jun; 19(3 Suppl 9):41-7. PubMed ID: 1641656
[TBL] [Abstract][Full Text] [Related]
3. The clinical rationale for S-phase radiosensitization in human tumors.
McGinn CJ; Kinsella TJ
Curr Probl Cancer; 1993; 17(5):273-321. PubMed ID: 8281809
[TBL] [Abstract][Full Text] [Related]
4. The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status, and future prospects: non-hypoxic cell sensitizers.
Kinsella TJ; Mitchell JB; Russo A; Morstyn G; Glatstein E
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1399-406. PubMed ID: 6381432
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer.
Vokes EE; Haraf DJ; Panje WR; Schilsky RL; Weichselbaum RR
Semin Oncol; 1992 Jun; 19(3 Suppl 9):53-8. PubMed ID: 1641658
[TBL] [Abstract][Full Text] [Related]
6. Radiobiology and clinical application of halogenated pyrimidine radiosensitizers.
Mitchell JB; Russo A; Cook JA; Straus KL; Glatstein E
Int J Radiat Biol; 1989 Nov; 56(5):827-36. PubMed ID: 2573682
[TBL] [Abstract][Full Text] [Related]
7. Antimetabolite radiosensitizers.
Shewach DS; Lawrence TS
J Clin Oncol; 2007 Sep; 25(26):4043-50. PubMed ID: 17827452
[TBL] [Abstract][Full Text] [Related]
8. Chemical radiosensitizers in cancer therapy.
Shenoy MA; Singh BB
Cancer Invest; 1992; 10(6):533-51. PubMed ID: 1422891
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in radiosensitization.
Linam J; Yang LX
Anticancer Res; 2015 May; 35(5):2479-85. PubMed ID: 25964520
[TBL] [Abstract][Full Text] [Related]
10. Clinical use of radiation sensitizing agents.
Goffinet DR; Bagshaw MA
Cancer Treat Rev; 1974 Mar; 1(1):15-26. PubMed ID: 4143475
[No Abstract] [Full Text] [Related]
11. [Trial and results of improved radiotherapy for cancer. 5. Radiotherapy with simultaneous administration of radio-sensitizing agents. Administration of halogenated pyrimidine].
Tanaka N; Takahashi M
Nihon Rinsho; 1972 Dec; 30(12):2655-8. PubMed ID: 4675997
[No Abstract] [Full Text] [Related]
12. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
[TBL] [Abstract][Full Text] [Related]
13. [Radiosensitization research in cancer therapy].
Sugahara T
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):405-11. PubMed ID: 3890755
[TBL] [Abstract][Full Text] [Related]
14. Combination of radiosensitizers and hyperthermia in tumour radiotherapy.
Brückner V
S Afr Med J; 1981 Jan; 59(4):116-7. PubMed ID: 7006107
[TBL] [Abstract][Full Text] [Related]
15. An approach to the radiosensitization of human tumors.
Kinsella TJ
Cancer J Sci Am; 1996; 2(4):184-93. PubMed ID: 9166528
[TBL] [Abstract][Full Text] [Related]
16. Novel radiosensitizers for tumors of the central nervous system.
Mehta MP; Suh JH
Curr Opin Investig Drugs; 2004 Dec; 5(12):1284-91. PubMed ID: 15648950
[TBL] [Abstract][Full Text] [Related]
17. Application of Radiosensitizers in Cancer Radiotherapy.
Gong L; Zhang Y; Liu C; Zhang M; Han S
Int J Nanomedicine; 2021; 16():1083-1102. PubMed ID: 33603370
[TBL] [Abstract][Full Text] [Related]
18. Taxanes as radiosensitizers.
Golden EB; Formenti SC; Schiff PB
Anticancer Drugs; 2014 May; 25(5):502-11. PubMed ID: 24335716
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran- 5,6-dione), a novel DNA repair inhibitor.
Boothman DA; Greer S; Pardee AB
Cancer Res; 1987 Oct; 47(20):5361-6. PubMed ID: 3652040
[TBL] [Abstract][Full Text] [Related]
20. GBM radiosensitizers: dead in the water…or just the beginning?
Bindra RS; Chalmers AJ; Evans S; Dewhirst M
J Neurooncol; 2017 Sep; 134(3):513-521. PubMed ID: 28762004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
